A Scoping Review on Epidemiological Risk Factors and Treatment Modalities for Snakebites in India
Soumyajit Saha1, Swati Behera1, Srajana U Kotekar1
1Post Graduate Student, Department of Global Public Health Policy and Governance, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Background:
Snakebite is a major public health concern in India and is associated with high rates of morbidity and mortality. Death and significant health repercussions caused by snakebites can be effectively mitigated with easy access to safe and effective antivenoms and enhanced awareness among healthcare professionals and the general public.
Objectives:
This review investigates the factors influencing snakebite outcomes and the current treatment options in India.
Materials And Methods:
The literature search was conducted using PubMed, Scopus, Google Scholar, Web of Science, and grey literature from World Health Organization and Government of India databases, focusing on studies published between 2012 and 2022. Inclusion criteria encompassed cross-sectional, intervention, descriptive, qualitative studies, case reports, and case series published in English, concentrating on snakebite envenoming.
Results:
Key findings included a lack of community awareness regarding early identification and management of snakebites, insufficient information on updated treatment protocols among healthcare providers, poor health-seeking behavior of victims, high reliance on untrained folk healers for initial treatment, and inadequate availability of anti-snake venom. These factors significantly impact snakebite-related outcomes.
Conclusion:
This scoping review provides valuable insights on the formulation of evidence-based policies that focus on reducing the impact of snakebite and improving patient outcomes in India, with the ultimate goal of achieving a 50% reduction in the number of deaths and cases of disability due to snakebite by 2030.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:26Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...